Sculptor Capital LP Geron Corp Transaction History

Sculptor Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	BUY	$1.76 - $6.38 $344,432 - $1.25 Million	195,700 Added 181.2%	303,700 $535,000
Q2 2018 Aug 13, 2018	SELL	$3.29 - $4.82 $355,649 - $521,042	-108,100 Reduced 50.02%	108,000 $370,000
Q1 2018 May 14, 2018	BUY	$1.81 - $5.98 $391,141 - $1.29 Million	216,100 New	216,100 $0

306

465M

1.07M

648K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $895M
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.